https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accrual-carrying-value-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/aoci https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-realized-loss https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-gross-realized-losses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/contractual-obligation https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/convertible-securities-retired https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/decrease-in-restricted-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-revenue-additions https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/dividends-payable-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/dividends-preferred-stock https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/eps https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/equity-method-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/expense-related-to-distribution-or-servicing-and-underwriting-fees https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/incremental-common-shares-attributable-to-equity-unit-purchase-agreements https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/inventory https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/land-subject-to-ground-leases https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/liabilities-assumed https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/number-of-countries-in-which-entity-operates https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/number-of-properties-subject-to-ground-leases https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/paid-in-capital-dividends-in-excess-of-retained-earnings https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/restricted-cash-current https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/revenue https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/share-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/tax-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/alder-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted